4D-QSAR Models Applied to the Study of TGF- β1 Receptor Inhibitors

Area of Science:

• Medicinal Chemistry
• Computational Chemistry
• Drug Discovery

Background:

• Transforming Growth Factor-beta (TGF-β) signaling is crucial in cellular processes and implicated in tumor progression.
• TGF-β1 receptor is a key target for cancer therapy due to its role in tumor invasiveness and metastasis.
• Quantitative Structure-Activity Relationship (QSAR) methods, including 4D-QSAR, are vital for designing new drug molecules.

Purpose of the Study:

• To develop robust 4D-QSAR models for aryl pyrimidine derivatives targeting the TGF-β1 receptor.
• To identify key structural features influencing the inhibitory activity of these compounds.
• To propose novel aryl pyrimidine derivatives with enhanced anti-cancer potential.

Main Methods:

• Generated conformational ensembles using molecular dynamics simulations.
• Utilized Grid Cell Occupancy Descriptors (GCOD) derived from pharmacophore interactions.
• Validated 4D-QSAR models through internal and external statistical parameters.
• Performed molecular docking to elucidate binding modes within the TGF-β active site.

Main Results:

• Developed a 4D-QSAR model with significant statistical validity (R²=0.89, q²=0.68).
• Identified critical pharmacophore groups essential for inhibitory activity.
• Molecular docking provided insights into structure-activity relationships and potential modifications.

Conclusions:

• The established 4D-QSAR model demonstrates high fitness, robustness, and predictive power.
• Identified structural modifications can enhance the potency of aryl pyrimidine derivatives.
• Proposed five novel aryl pyrimidine derivatives as promising candidates for cancer drug development.